Abstract
With aging, most older adults are at risk of having more than two diseases, conventionally defined as multimorbidity. We determined body organ disease number (BODN) as a new multimorbidity index. We measured the degree to which each disease level, from mild to severe, predicts longitudinal BODN uncoupled from chronological age. We determined Body Clock using global disease levels burden from all systems predicting longitudinal BODN for each individual, which is a proxy of the personalized rate of biological aging. Change in Body Clock predicts late-life age-related outcomes and can be used for geriatric clinics and clinical trials for precision medicine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Shabnam Salimi is funded by NIA-B K01AG059898 Shabnam Salimi is a special volunteer at NIA/IRP.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study participants of BLAS and InCHIANTI studies have signed the informed consent form to use the collected data for the research after their recruitment. Both BLSA and InCHIANTI studies have an overall IRB approval at NIA/IRP to use the data and for the present work. The ethics oversight the collection of the original data at the time of data collection. The current work is the secondary data analyses and IRB regards the present study in its entirety.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The coauthors' first name and last name order needed to be corrected. Now the name is First name and last name in order.The second author's first name is Aki and the last name is Vehtari.
Data Availability
The data are available upon formal request to BLSA and InCHIANTI studies.